Faust Tells Congress: Don't Downsize Research

University President Drew Faust testified before a Congressional committee this morning, urging lawmakers...

University President Drew Faust testified before a Congressional committee this morning, urging lawmakers not to cut—or even level-fund—the federal budget for scientific research grants at this critical juncture.

The leveling off of grant funding through the National Institutes of Health has caused a slowdown in the sciences similar to the downturn gripping the U.S. economy, Faust said. Coming on the heels of an earlier expansion—the NIH budget doubled between 1998 and 2003—the flat funding has left "brilliant young researchers...stuck behind their mentors in a funding queue that is stalling promising careers in academic research and pushing many with substantial promise to seek alternative paths," she told the Senate Committee on Health, Education, Labor, and Pensions this morning, according to her remarks as prepared for delivery.

"NIH will spend $30 billion this year in labs across this country that will continue to produce startling new results – for which we thank you sincerely," Faust said. "But we cannot afford to simply tread water."

Questions of diagnosing, treating, and even curing cancer are becoming more pressing as baby boomers reach a more cancer-prone period of life, but Faust said that investigators, instead of stepping up the pace, "are downsizing labs, slowing research, and producing more conservative, less ambitious proposals that are more likely to secure funding."

Faust provided her listeners with a copy of a new report, “A Broken Pipeline? Flat Funding of the NIH Puts a Generation of Science at Risk,” that was also released today. The report is a collaborative effort from Harvard, Brown, Vanderbilt, and UCLA; Partners Healthcare, the parent organization of two of Harvard Medical School's largest affiliated hospitals; the Duke University School of Medicine; and the Ohio State University Medical Center.

To assess the current climate for research, Faust said, "We interviewed 12 brilliant junior faculty at seven institutions across the country, who work in several different fields. ...These researchers were trained at some of the best institutions in the world, mentored by leaders in their scientific fields, have been recognized for their early work, and hold tremendous promise for the future of science. If these scholars are struggling, it is clear that as a nation we most certainly have a problem."

The report is available here. Faust's full testimony, as prepared, is available here.

Related topics

You might also like

Harvard Revamps Controversial Public Health School Center

The health and human rights center had drawn attention for its Palestine-related program.

Five Questions with Michèle Duguay

A Harvard scholar of music theory on how streaming services have changed the experience of music

Harvard Faculty Discuss Tenure Denials

New data show a shift in when, in the process, rejections occur

Most popular

Harvard Students, Alumna Named Rhodes and Marshall Scholars

Nine Rhodes and five Marshall scholars will study in the U.K. in 2026.

Explore More From Current Issue

Skyline view of Harvard University with trees in autumn colors and a river under a cloudy sky.

Your Views on Conservatism on Campus, Doxxing, and More

Readers write in about international students at Harvard, the September-October cover, and changes at the Chan School of Public Health.

Aisha Muharrar with shoulder-length hair, wearing a green blazer and white shirt.

Parks and Rec Comedy Writer Aisha Muharrar Gets Serious about Grief

With Loved One, the Harvard grad and Lampoon veteran makes her debut as a novelist.

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.